Connect with us


Ricki Fairley appointed to Xeris Biopharma Board of Directors



Xeris Biopharma Holdings has appointed Ricki Fairley to its Board of Directors.

Fairley currently serves as co-founder and CEO of TOUCH, The Black Breast Cancer Alliance and is also co-host for The Doctor Is In, a weekly live breast cancer advocacy web series

Fairley has over 35 years of marketing experience including 20 years in brand management at Johnson & Johnson, Nabisco, Reckitt & Colman and The Coca-Cola Company, and over 15 years in agency leadership encompassing strategic planning and consulting for numerous Fortune 500 companies.

Xeris chairman and CEO, Paul R. Edick, said:

“On behalf of our Board, we welcome Ricki and her wealth of insights and experiences, especially her passion for advocating on behalf of patient.

“As a seasoned marketer with 35+ years in brand management and strategic planning, we look forward to collaborating with Ricki to advance our mission of serving patient communities.”

Xeris is a biopharmaceutical company aiming to improve patients’ lives by developing and commercialising innovative products across a range of therapies.

The company has three commercially available products: Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; Keveyis, a proven therapy for primary periodic paralysis; and Recorle for the treatment of endogenous Cushing’s syndrome.

It has a diverse pipeline of development and partnered programmes using its formulation sciences, XeriSol and XeriJect, to support long-term product development.

Ricki Fairley said:

“I am thrilled to join this board of astute business strategists.

“I look forward to bringing my patient advocate voice to the company’s passionate and committed pursuit of changing patients’ lives.”

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories